HOME >> BIOLOGY >> NEWS
American Chemical Society's Weekly PressPac -- Aug. 1, 2007

>

CONTACT:
Awni Al-Otoom, Ph.D.
Jordan University of Science and Technology
Irbid, Jordan
Phone: 962-651-55058
Fax: 962-65155058
E-mail: awni_otoom@just.edu.jo


ARTICLE #2 FOR IMMEDIATE RELEASE

Bright future for new drug delivery system intended to minimize side effects
Journal of the American Chemical Society

In an advance toward the long-sought ability to deliver medication directly to diseased tissue, while minimizing side effects and damage to healthy parts of the body, scientists are reporting development of a new dosing system that is controlled by light. The study is scheduled for the August 15 issue of the Journal of the American Chemical Society, a weekly journal.

Colin P. McCoy and colleagues in Northern Ireland describe their new molecular-scale dosing devices as a new paradigm for precise control of drug dosing using light. The devices consist of medications that are combined with certain chemical compounds that respond to light in ways that release precisely controlled amounts of the drug. Drug release begins when light falls on the compounds, and lasts only as long as the light continues to shine.

The study reports successful laboratory tests of the system in the controlled release of three common medications used to treat pain and inflammation aspirin, ibuprofen and ketoprofen. One potential use cited in the study would be in the treatment of urinary catheter infections, where the drug is held latently in the catheter, and is released when needed. The system could be applied for other conditions using an implant under the skin for precisely controlled drug dosing, the researchers suggest.

ARTICLE #2 FOR IMMEDIATE RELEASE Light-Triggered Molecule-Scale Drug Dosing Devices

DOWNLOAD PDF http://p
'"/>


Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
6-Aug-2007


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
3. American Chemical Society meets Aug. 19-23 in Boston
4. American buffalo slaughter fueled by international trade
5. American Chemical Societys Weekly PressPac -- July 25, 2007
6. American Chemical Societys Weekly PressPac -- July 18, 2007
7. American Chemical Societys Weekly PressPac -- July 11, 2007
8. Tips from the Journals of the American Society for Microbiology
9. Wiley extends publishing partnership with the American Institute of Chemical Engineers
10. Highlights from the July 2007 Journal of the American Dietetic Association
11. Scientific American launches innovative new version of magazine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: American Chemical Society Weekly PressPac Aug

(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3
(Date:7/25/2014)... A new study by researchers from the University ... tiny nanosystems function, unlocking the potential to create ... study, which has been published in the prestigious ... a novel laser technique to examine in rich ... a small cluster containing an acetylene molecule and ...
(Date:7/25/2014)... 25, 2014 Lawrence Livermore scientists Charles ... Reuters list of " The World's Most Influential Scientific ... the 3,000 researchers who were identified by analyzing citation ... who published the highest-impact work (2002-2012 and 2012-2013). The ... combustion modeling . , "This recognition is a ...
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)...  ECC West Africa, LLC (ECC) signed a contract ... College Hospital (UCH) Ibadan Board of Management for the ... construct, and operate and maintain a new, state-of-the-art Cancer ... the first of the 4-phase project, ECC will conduct ... UCH Ibadan intends to finance and develop the Cancer ...
Breaking Biology Technology:Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2
Cached News: